Otsuka Pharmaceutical Development & Commercialization, Inc.
Clinical trials sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc., explained in plain language.
-
New pill aims to curb excessive urination in rare genetic disorder
Disease control Not yet recruitingThis early-stage trial tests a daily capsule called NDI-5001 in 24 adult men with a rare inherited kidney condition that causes extreme thirst and urination. The main goal is to check safety and how the drug affects urine output and concentration. Participants must have a confirm…
Phase: PHASE1 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
Healthy men needed to track experimental Drug's path through the body
Knowledge-focused Not yet recruitingThis early-stage trial will give a single oral dose of a radioactive-labeled drug (SEP-380135) to 8 healthy men to see how it is absorbed, broken down, and eliminated. The study does not aim to treat any disease, but to gather important information for future research. Participan…
Phase: PHASE1 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC